A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All

The need for new “pull” incentives to stimulate antibiotic R&D is widely recognized. Due to the global diversity of health systems, combined with different challenges faced by antibiotics used in different types of healthcare settings, there is no one-size-fits-all solution. Instead, different “...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of law, medicine & ethics medicine & ethics, 2018-06, Vol.46 (1_suppl), p.59-65
Main Authors: Bhatti, Taimur, Lum, Ka, Holland, Silas, Sassman, Stephanie, Findlay, David, Outterson, Kevin
Format: Article
Language:English
Subjects:
Antibiotics
Antimicrobial agents
Costs
Decision making
Generic products
Health care policy
Health technology assessment
Incentives
Infections
Innovations
Market entry
Patients
Pharmaceutical industry
Policy making
Public health
R&D
Reimbursement
Research & development
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The need for new “pull” incentives to stimulate antibiotic R&D is widely recognized. Due to the global diversity of health systems, combined with different challenges faced by antibiotics used in different types of healthcare settings, there is no one-size-fits-all solution. Instead, different “pull” incentives should be tailored to local contexts, priorities, and antibiotic types. Policymakers and industry should collaborate to identify appropriate solutions at the local, regional, and global levels.
ISSN:1073-1105
1748-720X
DOI:10.1177/1073110518782916